Cradle Genomics is a creator of a novel prenatal testing methodology. Founded by Rich Shippy in 2018, Cradle Genomics is backed by investors that include Alexandria Real Estate Equities, Axon Ventures, Illumina Ventures, Sea Lane Ventures, and Section 32 and is headquartered in San Diego.